About Meitetsu Hospital
名古屋鉄道健康保険組合名鉄病院は、愛知県名古屋市西区栄生二丁目26番11号の栄生駅前にある名古屋鉄道系の病院である。名古屋鉄道健康保険組合の直営として運営されている。 栄生駅と直結しており、同駅には「名鉄病院前」という副称が駅名標に付記されている。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Boehringer Ingelheim
2
ASKA Pharmaceutical Co., Ltd.
1
Bayer
1
Clinical Trials at Meitetsu Hospital
During the past decade, Meitetsu Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease
2008-12-01
2012-07-01
Completed
40
Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
2009-08-01
2013-01-01
Completed
32
Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
2010-12-01
2013-12-01
Terminated
53
A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding
2018-03-30
2021-07-12
Terminated
153
Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
2019-05-08
2020-09-28
Completed
335
A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years
2020-10-05
2022-08-26
Completed
129
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
2022-01-11
2023-07-04
Active, not recruiting
714
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Meitetsu Hospital"
#1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Meitetsu Hospital
According to Clinical.Site data, the most researched conditions in "Meitetsu Hospital" are
"Alzheimer's Disease" (2 trials), "Alzheimer Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Endometriosis" (1 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "Meitetsu Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Meitetsu Hospital
Most popular intervention types in "Meitetsu Hospital" are "Drug" (4 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "ACC-001" (3 trials), "Empagliflozin" (2 trials), "QS-21" (2 trials), "BI 690517" (1 trials) and "Leuprorelin acetate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Meitetsu Hospital
The vast majority of trials in "Meitetsu Hospital" are
5 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Meitetsu Hospital
Currently, there are NaN active trials in "Meitetsu Hospital".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Meitetsu Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Meitetsu Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".